Lehrstuhl für Strahlentherapie

Auswirkungen der Kombination des Ligase IV Inhibitors SCR7 mit ionisierender Strahlung auf HNO-Tumorzelllinien und Normalgewebszellen (2022) Hildebrand L, Jost T, Hecht M, Fietkau R, Distel L Conference contribution, Abstract of a poster Low-dose-rate Prostate Brachytherapy: Characterization of Seeds Dynamics within the Prostate (2022) Karius A, Lotter M, Kreppner S, Lubgan D, Grigo J, Fietkau R, Strnad V, Bert C Conference contribution Reporting and Evaluation System for Incidents in the Radiation Therapy to increase Patient Safety, Treatment Quality and the Efficiency of Process Flows (2022) Kornek D, Lang-Welzenbach M, Beck A, Reinhardt A, Brandt T, Bert C Conference contribution Phase II Study: Accelerated Partial Breast Irradiation (APBI) on a Linear Accelerator (2022) Ott O, Schweizer C, Strnad V, Stillkrieg W, Lambrecht U, Fietkau R Conference contribution LDRT induces long-lasting Pain and Immunomodulating Effects in chronic degenerative and inflammatory Diseases - Results from the IMMO-LDRT01 Study (2022) Donaubauer AJ, Weissmann T, Fröhlich B, Becker I, Ott O, Fietkau R, Gaipl U, Frey B Conference contribution Magnetic Resonance thermometry images of hyperthermia treatments of sarcomas for prediction of therapy responses-need of data reprocessing and cleaning (2022) Khatun R, Hader M, Schmidt M, Bert C, Wadepohl M, Fietkau R, Ott J, et al. Conference contribution Development of Recurrence and Long-term Toxicity in Prostate Carcinoma after combined Radiotherapy with interstitial Brachytherapy Boost (2022) Schweizer C, Strnad V, Fietkau R Conference contribution Both Gender and Inflammatory Status play a Role in the low-dose Rontgen Therapy Effect on Synovial Fibroblasts (2022) Völlings A, Piltz M, Titova E, Wolff T, Weissmann T, Fietkau R, Frey B, et al. Conference contribution Integration of a Halcyon Accelerator with ARIA in a Mosaiq - Environment - Risk Analysis Procedure (2022) Shariff M, Lotter M, Lambrecht U, Bert C Conference contribution Hypofractionated Irradiation increases the Expression of the Immune Checkpoint Molecule HVEM on TS/A, 4T1-luc and E0771 Breast Carcinoma Cells (2022) Flohr AS, Fietkau R, Rückert M, Gaipl U Conference contribution